Chemotherapy News and Research

Latest Chemotherapy News and Research

Yale researchers develop new method to predict likely resistance paths to cancer treatments

Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.

1 Mar 2018

Nut consumption linked to colon cancer survival

People with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don't, according to a new, large study led by researchers at Yale Cancer Center.

1 Mar 2018

Breast cancer and lymphoma survivors at greater risk of developing heart failure

Patients who were treated for breast cancer or lymphoma are more than three times at risk for developing congestive heart failure, compared with patients who did not have cancer. Congestive heart failure is when the heart muscle does not pump blood as well as it should.

28 Feb 2018

FUJIFILM SonoSite SII ultrasound system offers better solution for chemotherapy patients

Point-of-care ultrasound is helping to improve the quality of life for metastatic breast cancer patients in the West Midlands thanks to the fundraising efforts of Breast Friends Solihull and the University Hospitals Birmingham Charity.

From FUJIFILM Corporation 28 Feb 2018

Concerns raised about saline in intravenous fluid

A new set of studies has explored the saline used in intravenous fluids in hospitals and found that they may not be as safe as earlier believed. These two large studies have found that the presently used concentration of saline leads to an increased risk of kidney damage and death and replacing them with an alternate fluid could reduce the deaths by 50,000 to 70,000 and reduce the number of kidney failures by 100,000 annually in the United States.

27 Feb 2018

Telomere length testing can alter treatment decisions for certain diseases

Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.

27 Feb 2018

Carnegie Mellon to help develop novel camera that peers deep beneath the skin

Carnegie Mellon University is part of a five-year, $10 million program sponsored by the National Science Foundation to develop a new type of camera that peers deep beneath the skin to help diagnose and monitor a wide variety of health conditions.

27 Feb 2018

Connection between heart disease and cancer treatment

Advances in cancer treatment have resulted in a growing number of cancer survivors. However, powerful treatments such as chemotherapy, radiation treatments and some cancer drugs are not without their risks, including the potential for serious, long-term damage to the heart.

24 Feb 2018

UC Riverside researchers discover way to halt cancer metastasis

A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

23 Feb 2018

Efficacy of cancer immunotherapy increased by deactivating tumor defence mechanism

Novel bifunctional immunotherapeutic agents have been developed that, as well as deactivating key immune checkpoints,deactivate the tumor's protective response.

23 Feb 2018

Calorie restriction improves intestinal-tissue regeneration after injury

Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most animal species examined.

22 Feb 2018

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.

22 Feb 2018

Zika virus could be alternative for treatment of aggressive brain cancer

Zika virus, feared for causing microcephaly in babies whose mothers were infected during pregnancy by attacking the cells that will give rise to the fetus's cerebral cortex, could be an alternative for treatment of glioblastoma, the most common and aggressive kind of malignant brain tumor in adults.

21 Feb 2018

Local environment plays crucial role in aggressiveness of breast cancer

Breast cancer is the most commonly diagnosed cancer in women -- one in eight (12.4 percent) in the U.S. will be diagnosed with it. Invasive breast cancer is dangerous for two reasons: It can aggressively spread to other organs in the body, and it is likely to recur.

21 Feb 2018

Scientists show that cutting-edge technique can efficiently sort nano-sized particles

A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body's intercellular delivery service to spread to new locations in the body.

From Waters | Wyatt Technology 21 Feb 2018

Researchers target abnormal epigenetic mechanisms involved in childhood cancers

Several childhood cancer cell types show features of immature neural cells, and there is evidence suggesting that these tumors may arise from neural crest stem cells that underwent abnormal changes during embryonic development.

20 Feb 2018

Computerized tissue-imaging may help predict early recurrence of lung cancer

Case Western Reserve and Cleveland Clinic are leading development of a computerized tissue-imaging program that could soon help identify which lung cancer patients are likely to face an earlier recurrence of the disease.

20 Feb 2018

New genetic risk score could help guide screening decisions for prostate cancer

One of the biggest challenges in treating prostate cancer is distinguishing men who have aggressive and potentially lethal disease from men whose cancer is slow-growing and unlikely to metastasize.

20 Feb 2018

Liquid biopsies could be used as new predictive marker for metastatic TNBC

A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer, according to new research published by a multi-institutional team of researchers with The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

19 Feb 2018

Research finds rising trend in incidence of merkel cell carcinoma

Merkel cell carcinoma is a rare type of skin cancer, affecting only a few thousand people each year, compared to tens of thousands with melanoma. But while it may not be as common as other skin cancers, MCC is highly aggressive and often deadly -; and it's also becoming more common, according to new research published in the Journal of the American Academy of Dermatology and presented at the American Academy of Dermatology 2018 Annual Meeting in San Diego.

19 Feb 2018